A prospective randomized trial from Turkey comparing octreotide versus injection sclerotherapy in acute variceal bleeding

Hepato-Gastroenterology

Volumn 47, Issue 31, 2000, Pages 168-173

  Sivri, Bulent ^a,b   Oksuzoglu, Gurol ^a   Bayraktar, Yusuf ^a   Kayhan, Burhan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Acute variceal hemorrhage; Esophageal varices; Octreotide; Sclerotherapy

Indexed keywords

HYPOTHALAMUS RELEASE INHIBITING FACTOR; OCTREOTIDE; POLIDOCANOL;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ESOPHAGUS VARICES BLEEDING; FEMALE; FIBERSCOPE ENDOSCOPY; HOMEOSTASIS; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PORTAL HYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESUSCITATION; SCLEROTHERAPY; TREATMENT OUTCOME; TURKEY (REPUBLIC);

ACUTE DISEASE; ADULT; AGED; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HEMOSTATICS; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; OCTREOTIDE; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TURKEY;

EID: 0033951342     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. 1 Chan LY, Sung JJY: Review article: the role of pharmacotherapy for acute variceal haemorrhage in the era of endoscopic haemostasis. Aliment Pharmacol Ther 1997; 11:45-50.
2. 2 Williams SGJ, Westaby D: Management of variceal hemorrhage. Br Med J 1994; 308:1213-1217.
3. 3 Westaby D, Hayes PC, Glimson AES, et al: Controlled clinical trial of injection sclerotherapy for acute variceal bleeding. Hepatology 1989; 9:274-277.
4. 4 Fardy JM, Laupacis A: A metaanalysis of prophylactic endoscopic sclerotherapy for esophageal varices. Am J Gastroenterol 1994; 89:1938-1948.
5. 5 Battershill PE, Clissold SP: Octreotide; A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion. Drugs 1989; 38:658-702.
6. 6 Cello JP, Chan MF: Octreotide therapy for variceal hemorrhage. Digestion 1993; 54(Suppl 1):20-26. (Review)
7. 7 Law AW, Gales MA: Octreotide or vasopressin for bleeding esophageal varices. Ann Pharmacother 1997; 31:237-238.
8. 8 Hwang SJ, Lin HC, Chang CF, et al: A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 1992; 16:320-325.
9. 9 McKee RF: Sandostatin therapy of acute oesophageal variceal bleeding. Digestion 1993; 54(Suppl 1):27-29.
10. 10 McKee RF, Garden OJ, Anderson JR, et al: A comparison of SMS 201-995 and oesophageal tamponade in the control of acute variceal haemorrhage. HPB Surgery 1992; 6:7-17.
11. 11 Rees CJ, Hudson M, Record CO: Therapeutic modalities in portal hypertension. European J Gastroenterol Hepatol 1997; 9:9-11.
12. 12 Burroughs AK: Medical management of bleeding esophageal varices. Dig Dis 1992; 10(Suppl 1):30-37.
13. 13 Armitage P, Berry G: Statistical methods in medical research. 2nd Edition. Oxford, England: Blackwell, 1987, pp. 131-142, 163-169, 219-227.
14. 14 Cary NC (Ed.): SAS/STAT guide for personal computers. Version 6.0. SAS Institute, 1987.
15. 15 Sung JJ: Non-surgical treatment of variceal haemorrhage. Br J Hosp Med 1997; 57:162-166.
16. 16 Scarpignato C: Clinical pharmacology of active variceal bleeding. Dig Dis 1992; 10(Suppl 1):16-29. (Review)
17. 17 Burroughs AK, McCormick PA: The pharmacotherapy of portal hypertension. In: Pounder RE (Ed.). Recent Advances in Gastroenterology. London: Churchill Livingstone, 1992; pp. 171-193.
18. 18 Roberts LR, Kamath PS: Pathophysiology and treatment of variceal hemorrhage. Mayo Clin Proc 1996; 71:973-983.
19. 19 Jenkins SA: Somatostatin in acute bleeding oesophageal varices. Drugs 1992; 44(Suppl 2):36-55.
20. 20 Harris AG: Octreotide in the treatment of disorders of the gastrointestinal system. Drug Invest 1992; 4(Suppl 3):1-54.
21. 21 Binmoeller KF, Soehendra N: Nonsurgical treatment of variceal bleeding: new modalities. Am J Gastroenterol 1995; 90:1923-1931.
22. 22 Avgerinos A, Nevens F, Raptis S, et al: Early administration of somatostatin and sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomized trial. Lancet 1997; 350:1495-1499.
23. 23 Nevens F, Van Steenbergen W, Yap SH, Fevery J: Assessment of variceal pressure by continuous non-invasive endoscopic registration: a placebo controlled evaluation of the effect of terlipressin and octreotide. Gut 1996; 38:129-134.
24. 24 Sung JJ, Chung SC, Yung MY, et al: Prospective randomized study of effect of octreotide on rebleeding from esophageal varices after endoscopic ligation. Lancet 1995; 346(8991-8992):1666-1669.
25. 25 Besson I, Ingrand P, Person B, et al: Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995; 333:555-560.
26. 26 Sung JJY, Chung SCS, Lai CW, et al: Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet 1993; 342:637-641.